Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1136/jnnp-2018-318090 | DOI Listing |
ANZ J Surg
January 2025
Department of Neurosurgery, Liaoyang City Central Hospital, Liaoyang, China.
Purpose: To investigate the safety and efficacy of endovascular embolization combined with external drainage for poor-grade ruptured cerebral aneurysms and risk factors.
Materials And Methods: Forty-six patients with poor-grade ruptured cerebral aneurysms treated with endovascular embolization combined with decompressive craniectomy and drainage were retrospectively enrolled.
Results: Coil embolization alone was performed in 29 (63.
Medicina (Kaunas)
November 2024
Department of Anatomy and Embryology, Faculty of Medicine, Complutense University of Madrid, 28040 Madrid, Spain.
: Vein of Galen aneurysmal malformations (VGAMs) represent the most common vascular malformations of the brain at the pediatric age. Comprehension of its angioarchitecture and clinical features may influence their treatment options and functional outcomes. The aim of this review is to give an update of the anatomical and technical aspects of the management of VGAMs after endovascular treatment.
View Article and Find Full Text PDFJ Craniofac Surg
December 2024
Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang, P.R. China.
Background: The stent-assisted coiling (SAC) and flow-diverter stent (FDS) techniques are widely used in the endovascular treatment of paraclinoid aneurysms. This article compares the occlusion rate, periprocedural complications, and clinical outcomes of SAC and FDSs.
Methods: Between January 2010 and December 2020, a systematic search of electronic databases identified 2283 articles for screening.
Ann Vasc Surg
December 2024
Department of Cardiovascular Surgery, Bursa City Hospital, Bursa, Turkey. Electronic address:
J Neurointerv Surg
December 2024
Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA
Background: Ticagrelor, a P2Y12 inhibitor, offers a rapid onset and consistent platelet inhibition, making it a viable alternative for dual antiplatelet therapy (DAPT). The optimal ticagrelor dose for neurointerventional procedures, however, remains unclear. We report our experience with ticagrelor 60 mg twice daily plus aspirin 81 mg daily compared with the standard aspirin and clopidogrel regimen for intracranial stenting.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!